Policy | February 28, 2024
NIA signs MoU with Department of Thai Traditional and Alternative Medicine
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The restructuring aims to create synergies across the business and strengthen capital structure
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Subscribe To Our Newsletter & Stay Updated
